De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-01-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003311 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832593965177634816 |
|---|---|
| author | Hanxu Guo Chengqi Jin Li Ding Jun Xie Jing Xu Ruiliang Wang Hong Wang Changcheng Guo Jiansheng Zhang Bo Peng Xudong Yao Jing Yuan Bin Yang Sihan Zhou |
| author_facet | Hanxu Guo Chengqi Jin Li Ding Jun Xie Jing Xu Ruiliang Wang Hong Wang Changcheng Guo Jiansheng Zhang Bo Peng Xudong Yao Jing Yuan Bin Yang Sihan Zhou |
| author_sort | Hanxu Guo |
| collection | DOAJ |
| format | Article |
| id | doaj-art-de0c561ee78a460e83fbeb5cb337e4c8 |
| institution | Kabale University |
| issn | 0366-6999 2542-5641 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj-art-de0c561ee78a460e83fbeb5cb337e4c82025-01-20T07:56:42ZengWolters KluwerChinese Medical Journal0366-69992542-56412025-01-01138223123310.1097/CM9.0000000000003311202501200-00015De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic reviewHanxu Guo0Chengqi Jin1Li Ding2Jun Xie3Jing Xu4Ruiliang Wang5Hong Wang6Changcheng Guo7Jiansheng Zhang8Bo Peng9Xudong Yao10Jing Yuan11Bin Yang12Sihan Zhou1 Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China2 Department of Urology, Urologic Cancer Institute, Tongji University School of Medicine, Shanghai 200072, China1 Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China4 Department of Urology, Shanghai Clinical College, Anhui Medical University, Shanghai 200072, China1 Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China1 Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China1 Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China1 Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China5 Department of Urology, Shanghai Tenth People’s Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China1 Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China1 Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China1 Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China1 Department of Urology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, Chinahttp://journals.lww.com/10.1097/CM9.0000000000003311 |
| spellingShingle | Hanxu Guo Chengqi Jin Li Ding Jun Xie Jing Xu Ruiliang Wang Hong Wang Changcheng Guo Jiansheng Zhang Bo Peng Xudong Yao Jing Yuan Bin Yang Sihan Zhou De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review Chinese Medical Journal |
| title | De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review |
| title_full | De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review |
| title_fullStr | De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review |
| title_full_unstemmed | De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review |
| title_short | De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review |
| title_sort | de novo patients with high volume metastatic hormone sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy network analysis and systematic review |
| url | http://journals.lww.com/10.1097/CM9.0000000000003311 |
| work_keys_str_mv | AT hanxuguo denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT chengqijin denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT liding denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT junxie denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT jingxu denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT ruiliangwang denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT hongwang denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT changchengguo denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT jianshengzhang denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT bopeng denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT xudongyao denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT jingyuan denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT binyang denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview AT sihanzhou denovopatientswithhighvolumemetastatichormonesensitiveprostatecancercanbenefitfromtheadditionofdocetaxeltotriplettherapynetworkanalysisandsystematicreview |